1. Antiangiogenic treatment approaches in breast cancer. (September 2013) Authors: Bartsch, Rupert; Berghoff, Anna S; Preusser, Matthias; Steger, Guenther G; Zielinski, Christoph C Journal: Breast cancer management Issue: Volume 2:Number 5(2013) Page Start: 397 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bevacizumab: no comeback in early breast cancer?. Issue 9 (September 2015) Authors: Bartsch, Rupert; Gnant, Michael; Steger, Guenther G Journal: Lancet oncology Issue: Volume 16:Issue 9(2015:Sep.) Page Start: 1001 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bevacizumab: no comeback in early breast cancer?. Issue 9 (September 2015) Authors: Bartsch, Rupert; Gnant, Michael; Steger, Guenther G Journal: Lancet oncology Issue: Volume 16:Issue 9(2015:Sep.) Page Start: 1001 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CDK4/6 inhibitors in luminal breast cancer. Issue 1 (January 2015) Authors: Gnant, Michael; Steger, Guenther G; Bartsch, Rupert Journal: Lancet oncology Issue: Volume 16:Issue 1(2015:Jan.) Page Start: 2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CDK4/6 inhibitors in luminal breast cancer. Issue 1 (January 2015) Authors: Gnant, Michael; Steger, Guenther G; Bartsch, Rupert Journal: Lancet oncology Issue: Volume 16:Issue 1(2015:Jan.) Page Start: 2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Pathological complete remission and long-term outcome—what do we know in 2016?. Issue 6 (June 2016) Authors: Gnant, Michael; Steger, Guenther G; Bartsch, Rupert Journal: Lancet oncology Issue: Volume 17:Issue 6(2016:Jun.) Page Start: 693 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗